DexCom reported strong second-quarter results with a 25% increase in revenue to $871.3 million. The company also raised its full-year 2023 revenue and margin guidance, reflecting confidence in its growth trajectory and market opportunity.
Revenue grew 25% versus the same quarter of the prior year to $871.3 million.
U.S. revenue growth of 21% and international revenue growth of 38%.
GAAP operating income of $128.1 million or 14.7% of revenue.
Completed a $1.25 billion senior convertible notes offering.
The company is increasing fiscal year 2023 guidance for revenue, Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin at the following levels:
Visualization of income flow from segment revenue to net income